Literature DB >> 25384895

Facilitated communication and authorship: a systematic review.

Ralf W Schlosser1, Susan Balandin, Bronwyn Hemsley, Teresa Iacono, Paul Probst, Stephen von Tetzchner.   

Abstract

Facilitated Communication (FC) is a technique whereby individuals with disabilities and communication impairments allegedly select letters by typing on a keyboard while receiving physical support, emotional encouragement, and other communication supports from facilitators. The validity of FC stands or falls on the question of who is authoring the typed messages--the individual with a disability or the facilitator. The International Society for Augmentative and Alternative Communication (ISAAC) formed an Ad Hoc Committee on FC and charged this committee to synthesize the evidence base related to this question in order to develop a position statement. The purpose of this paper is to report this synthesis of the extant peer-reviewed literature on the question of authorship in FC. A multi-faceted search was conducted including electronic database searches, ancestry searches, and contacting selected authors. The authors considered synopses of systematic reviews, and systematic reviews, which were supplemented with individual studies not included in any prior reviews. Additionally, documents submitted by the membership were screened for inclusion. The evidence was classified into articles that provided (a) quantitative experimental data related to the authorship of messages, (b) quantitative descriptive data on the output generated through FC without testing of authorship, (c) qualitative descriptive data on the output generated via FC without testing of authorship, and (d) anecdotal reports in which writers shared their perspectives on FC. Only documents with quantitative experimental data were analyzed for authorship. Results indicated unequivocal evidence for facilitator control: messages generated through FC are authored by the facilitators rather than the individuals with disabilities. Hence, FC is a technique that has no validity.

Entities:  

Keywords:  Autism; Developmental disabilities; Facilitated Communication

Mesh:

Year:  2014        PMID: 25384895     DOI: 10.3109/07434618.2014.971490

Source DB:  PubMed          Journal:  Augment Altern Commun        ISSN: 0743-4618            Impact factor:   2.214


  7 in total

1.  Maintaining Professional Relationships in an Interdisciplinary Setting: Strategies for Navigating Nonbehavioral Treatment Recommendations for Individuals with Autism.

Authors:  Matthew T Brodhead
Journal:  Behav Anal Pract       Date:  2015-02-10

2.  Toward a Phenomenological Account of Embodied Subjectivity in Autism.

Authors:  Sofie Boldsen
Journal:  Cult Med Psychiatry       Date:  2018-12

Review 3.  The role of augmentative and alternative communication for children with autism: current status and future trends.

Authors:  Teresa Iacono; David Trembath; Shane Erickson
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570

Review 4.  Augmentative and Alternative Communication for Children with Intellectual and Developmental Disability: A Mega-Review of the Literature.

Authors:  Becky Crowe; Wendy Machalicek; Qi Wei; Christine Drew; Jay Ganz
Journal:  J Dev Phys Disabil       Date:  2021-03-31

5.  Perspective: Presuming Autistic Communication Competence and Reframing Facilitated Communication.

Authors:  Melanie Heyworth; Timothy Chan; Wenn Lawson
Journal:  Front Psychol       Date:  2022-03-10

Review 6.  Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders.

Authors:  Lindsay Pennington; Wanwuri A Akor; Kate Laws; Juliet Goldbart
Journal:  Cochrane Database Syst Rev       Date:  2018-07-24

7.  Development of a new high sensitivity mechanical switch for augmentative and alternative communication access in people with amyotrophic lateral sclerosis.

Authors:  M Caligari; M Godi; M Giardini; R Colombo
Journal:  J Neuroeng Rehabil       Date:  2019-11-29       Impact factor: 4.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.